Top Markets
Coin of the day
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
주식 순위 #40868
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
주가
$0.02765
마지막 동기화: 2024-12-23
시가총액
$69.04K
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Histogen Inc. (HSTO)

카테고리

Histogen Inc. (HSTO)의 주식 분할 이력
Histogen Inc. 주식 (심볼: HSTO)은 총 2회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Jun 03, 2022에 발생했습니다.
May 27, 2020 이전에 매수한 HSTO 주식 1주는 현재 0.005주의 HSTO 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
2022-06-03 1:20 x0.05 x0.005
2020-05-27 1:10 x0.1 x0.1
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE